TrialScientific reports2019

Intraperitoneal administration of fosfomycin, metronidazole, and granulocyte-macrophage colony-stimulating factor in patients undergoing appendectomy is safe: a phase II clinical trial.

Siv Fonnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.